Medikaloka Hermina PT Capital Reinvestment Ratio
Medikaloka Hermina PT capital reinvestment ratio. Medikaloka Hermina PT (HEAL) has a Capital Reinvestment Ratio of 1.96x as of June 2025, meaning it reinvests 2% of its operating cash flow (Rp225.37 Billion) in capital expenditures (Rp442.71 Billion). See Medikaloka Hermina PT free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Medikaloka Hermina PT (2015–2024)
Capital reinvestment ratio of Medikaloka Hermina PT from 2015 to 2024. This chart tracks Medikaloka Hermina PT's Capital Reinvestment Ratio across 10 annual periods. See financial flexibility index of Medikaloka Hermina PT to measure the company's free cash flow as a share of total liabilities.
Medikaloka Hermina PT Capital Reinvestment Ratio by Year (2015–2024)
Medikaloka Hermina PT capital reinvestment ratio by year from 2015 to 2024. For the full cash flow conversion analysis, see Medikaloka Hermina PT (HEAL) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.01x | Rp1.14 Trillion | Rp2.28 Trillion | ▲ +66.3% |
| 2023 | 1.21x | Rp1.32 Trillion | Rp1.59 Trillion | ▼ -46.2% |
| 2022 | 2.24x | Rp503.58 Billion | Rp1.13 Trillion | ▲ +242.9% |
| 2021 | 0.65x | Rp1.86 Trillion | Rp1.21 Trillion | ▼ -17.2% |
| 2020 | 0.79x | Rp1.13 Trillion | Rp889.65 Billion | ▼ -21.5% |
| 2019 | 1.01x | Rp572.58 Billion | Rp575.94 Billion | ▼ -68.2% |
| 2018 | 3.16x | Rp241.67 Billion | Rp764.16 Billion | ▲ +111.2% |
| 2017 | 1.50x | Rp465.08 Billion | Rp696.31 Billion | ▲ +11.3% |
| 2016 | 1.34x | Rp362.85 Billion | Rp487.92 Billion | ▼ -24.0% |
| 2015 | 1.77x | Rp255.71 Billion | Rp452.66 Billion | — |